HUP9901590A2 - Szubsztituált aza- és diaza-cikloheptán- és -ciklooktán-származékok, alkalmazásuk, a vegyületeket tartalmazó gyógyászati készítmények - Google Patents
Szubsztituált aza- és diaza-cikloheptán- és -ciklooktán-származékok, alkalmazásuk, a vegyületeket tartalmazó gyógyászati készítményekInfo
- Publication number
- HUP9901590A2 HUP9901590A2 HU9901590A HUP9901590A HUP9901590A2 HU P9901590 A2 HUP9901590 A2 HU P9901590A2 HU 9901590 A HU9901590 A HU 9901590A HU P9901590 A HUP9901590 A HU P9901590A HU P9901590 A2 HUP9901590 A2 HU P9901590A2
- Authority
- HU
- Hungary
- Prior art keywords
- cyclooctane
- derivatives
- diazacycloheptane
- compounds
- disubstituted
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 125000000640 cyclooctyl group Chemical class [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 title abstract 2
- QPMLSUSACCOBDK-UHFFFAOYSA-N diazepane Chemical compound C1CCNNCC1 QPMLSUSACCOBDK-UHFFFAOYSA-N 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 abstract 2
- 125000006570 (C5-C6) heteroaryl group Chemical group 0.000 abstract 1
- GYSCBCSGKXNZRH-UHFFFAOYSA-N 1-benzothiophene-2-carboxamide Chemical compound C1=CC=C2SC(C(=O)N)=CC2=C1 GYSCBCSGKXNZRH-UHFFFAOYSA-N 0.000 abstract 1
- -1 2-hydroxypyrimidinyl Chemical group 0.000 abstract 1
- KXDAEFPNCMNJSK-UHFFFAOYSA-N Benzamide Chemical group NC(=O)C1=CC=CC=C1 KXDAEFPNCMNJSK-UHFFFAOYSA-N 0.000 abstract 1
- 125000002837 carbocyclic group Chemical group 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 229960003638 dopamine Drugs 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 239000003446 ligand Substances 0.000 abstract 1
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 239000000843 powder Substances 0.000 abstract 1
- 125000004076 pyridyl group Chemical group 0.000 abstract 1
- 125000000714 pyrimidinyl group Chemical group 0.000 abstract 1
- 229920006395 saturated elastomer Polymers 0.000 abstract 1
- 125000000547 substituted alkyl group Chemical group 0.000 abstract 1
- 125000004306 triazinyl group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Cardiology (AREA)
- Psychiatry (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Luminescent Compositions (AREA)
Abstract
A szűbsztitűált aza- és diaza-ciklőheptán- vagy ciklőőktán-származékőkAr1-A-B-Ar2 (I) általánős képletében: Ar1 adőtt esetben szűbsztitűált benzőil-aminő-, (benzőtienil-karbőnil)-aminő-csőpőrt vagy 5 vagy 6 tagú heterőarilcsőpőrt; R1 hidrőgénatőm vagy adőtt esetben szűbsztitűált alkilcsőpőrt; R2 űgyanaz, mint R1, tővábbá -COR1 vagy -CO2R1 általánős képletűcsőpőrt; B 7 vagy 8 tagú, egy, vagy 1,4- vagy 1,5-helyzetben két nitrőgénatőmőtés adőtt esetben kettős kötést tartalmazó, kétértékű telítettheterőciklűsős csőpőrt; és Ar2 adőtt esetben szűbsztitűált és/vagy egy karbőciklűssal kőndenzáltfenil-, piridil-, pirimidinil- vagy triazinilcsőpőrt, azzal amegkötéssel, hőgy jelentése 2-hidrőxi-pirimidinil-csőpőrttól eltérő. Atalálmány szerinti vegyületek a dőpamin D3-receptőrőkkal szemben nagyés szelektív affinitást műtató, ennélfőgva a D3-receptőrőkligandjaival befőlyásőlható betegségek kezelésében alkalmazhatók. ŕ
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19600934A DE19600934A1 (de) | 1996-01-12 | 1996-01-12 | Substituierte Aza- und Diazacycloheptan- und Cyclooctanverbindungen und deren Verwendung |
PCT/EP1997/000106 WO1997025324A1 (de) | 1996-01-12 | 1997-01-10 | Substituierte aza- und diazacycloheptan- und -cyclooctanverbindungen und deren verwendung |
Publications (3)
Publication Number | Publication Date |
---|---|
HUP9901590A2 true HUP9901590A2 (hu) | 1999-08-30 |
HUP9901590A3 HUP9901590A3 (en) | 2002-01-28 |
HU228457B1 HU228457B1 (en) | 2013-03-28 |
Family
ID=7782613
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU9901590A HU228457B1 (en) | 1996-01-12 | 1997-01-10 | Substituted aza- and diazacycloheptane and cyclooctane derivatives, use thereof, pharmaceutical compositions containing there of |
Country Status (26)
Country | Link |
---|---|
US (2) | US6214822B1 (hu) |
EP (1) | EP0877744B1 (hu) |
JP (1) | JP4349657B2 (hu) |
KR (1) | KR100441073B1 (hu) |
CN (2) | CN1075070C (hu) |
AR (1) | AR005868A1 (hu) |
AT (1) | ATE273301T1 (hu) |
AU (1) | AU717726B2 (hu) |
BG (1) | BG64098B1 (hu) |
CA (1) | CA2241787C (hu) |
CO (1) | CO4790173A1 (hu) |
CZ (1) | CZ297981B6 (hu) |
DE (2) | DE19600934A1 (hu) |
ES (1) | ES2225947T3 (hu) |
HR (1) | HRP970021A2 (hu) |
HU (1) | HU228457B1 (hu) |
IL (1) | IL125076A (hu) |
MX (1) | MX9805499A (hu) |
NO (1) | NO316753B1 (hu) |
NZ (1) | NZ326332A (hu) |
PL (1) | PL327692A1 (hu) |
SK (1) | SK284987B6 (hu) |
TR (1) | TR199801302T2 (hu) |
TW (1) | TW475929B (hu) |
WO (1) | WO1997025324A1 (hu) |
ZA (1) | ZA97209B (hu) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19728996A1 (de) * | 1997-07-07 | 1999-01-14 | Basf Ag | Triazolverbindungen und deren Verwendung |
GB9810876D0 (en) | 1998-05-20 | 1998-07-22 | Smithkline Beecham Plc | Compounds |
WO2000021951A1 (en) | 1998-10-08 | 2000-04-20 | Smithkline Beecham Plc | Tetrahydrobenzazepine derivatives useful as modulators of dopamine d3 receptors (antipsychotic agents) |
TWI274750B (en) | 1999-01-12 | 2007-03-01 | Abbott Gmbh & Co Kg | Triazole compounds showing high affinity to dopamine D3 receptor and pharmaceutical composition comprising the same |
DE19922443A1 (de) * | 1999-05-07 | 2000-11-09 | Basf Ag | Verwendung von Dopamin-D3-Rezeptorliganden zur Herstellung von Arzneimittel für die Behandlung von Nierenfunktionsstörungen |
US7037916B2 (en) | 1999-07-15 | 2006-05-02 | Pharmacopeia Drug Discovery, Inc. | Pyrimidine derivatives as IL-8 receptor antagonists |
WO2001072306A1 (de) * | 2000-03-27 | 2001-10-04 | Basf Aktiengesellschaft | Verwendung von dopamin-d3-rezeptor-liganden zur behandlung von erkrankungen des zentralen nervensystems |
AU2002250107B8 (en) | 2001-02-16 | 2008-06-12 | Aventis Pharmaceuticals Inc. | Heterocyclic substituted carbonyl derivatives and their use as dopamine D3 receptor ligands |
DE10109866A1 (de) * | 2001-03-01 | 2002-09-05 | Abbott Gmbh & Co Kg | Triazolverbindungen und deren Verwendung zur Prophylaxe und Therapie neurodegenerativer Erkrankungen, Hirntrauma und zerebraler Ischämie |
DE10131543A1 (de) * | 2001-06-29 | 2003-01-16 | Abbott Lab | Pyrimidinoxyalkylpiperazine und ihre therapeutische Verwendung |
DE60233265D1 (de) * | 2001-11-28 | 2009-09-17 | Ipsen Pharma | 5-sulfanyl-4h-1,2,4-triazolderivate und deren verwendung zur behandlung von somatostatine vermittelten krankheiten |
WO2003077656A1 (en) * | 2002-03-15 | 2003-09-25 | Ciba Specialty Chemicals Holding Inc. | 4-aminopyrimidines and their use for the antimicrobial treatment of surfaces |
DE10304870A1 (de) * | 2003-02-06 | 2004-08-19 | Abbott Gmbh & Co. Kg | Triazolverbindungen und ihre therapeutische Verwendung |
TW200507841A (en) * | 2003-03-27 | 2005-03-01 | Glaxo Group Ltd | Antibacterial agents |
DE10358004A1 (de) * | 2003-12-11 | 2005-07-14 | Abbott Gmbh & Co. Kg | Ketolactam-Verbindungen und ihre Verwendung |
DE102004027358A1 (de) | 2004-06-04 | 2005-12-29 | Abbott Gmbh & Co. Kg | Pyrimidinverbindungen und ihre Verwendung |
FR2877005A1 (fr) * | 2004-10-22 | 2006-04-28 | Bioprojet Soc Civ Ile | Nouveaux derives d'arylpiperazine |
WO2006081289A2 (en) * | 2005-01-25 | 2006-08-03 | Glaxo Group Limited | Antibacterial agents |
JP2007106746A (ja) * | 2005-09-13 | 2007-04-26 | Tosoh Corp | 新規アリールホモピペラジン類、またはその塩と製造方法 |
EP1988077A4 (en) * | 2006-02-23 | 2009-09-02 | Shionogi & Co | NUCLEIC HETEROCYCLIC DERIVATIVES SUBSTITUTED BY CYCLIC GROUPS |
US20070293548A1 (en) * | 2006-03-31 | 2007-12-20 | Wang Eric Y | Inhibitors of semicarbazide-sensitive amine oxidase (SSAO) and VAP-1 mediated adhesion useful for treatment and prevention of diseases |
EP1882688A1 (en) * | 2006-07-25 | 2008-01-30 | EPFL Ecole Polytechnique Fédérale de Lausanne | Labelling of fusion proteins with synthetic probes |
JP4840440B2 (ja) * | 2008-12-24 | 2011-12-21 | ソニー株式会社 | 画像処理装置およびその方法、並びにプログラム |
GB0908394D0 (en) | 2009-05-15 | 2009-06-24 | Univ Leuven Kath | Novel viral replication inhibitors |
GB0913636D0 (en) | 2009-08-05 | 2009-09-16 | Univ Leuven Kath | Novel viral replication inhibitors |
SG182534A1 (en) * | 2010-01-25 | 2012-08-30 | Chdi Foundation Inc | Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof |
US9156822B2 (en) * | 2010-07-02 | 2015-10-13 | The University Of North Carolina At Chapel Hill | Functionally selective ligands of dopamine D2 receptors |
WO2012065963A2 (en) | 2010-11-15 | 2012-05-24 | Katholieke Universiteit Leuven | Novel antiviral compounds |
SI2750677T1 (sl) | 2011-08-30 | 2017-10-30 | Chdi Foundation, Inc. | Inhibitorji kinurenin-3-monooksigenaze, farmacevtski sestavki in postopki njihove uporabe |
MX2014002459A (es) | 2011-08-30 | 2014-04-10 | Chdi Foundation Inc | Inhibidores de quinurenina-3-monooxigenasa, composiciones farmaceuticas y metodos de uso de los mismos. |
KR102412220B1 (ko) | 2013-12-24 | 2022-06-23 | 온코타르티스, 아이엔씨. | 벤즈아미드 및 니코틴아미드 화합물 및 이를 사용하는 방법 |
AP2017009724A0 (en) | 2014-07-17 | 2017-01-31 | Chdi Foundation Inc | Methods and compositions for treating hiv-related disorders |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE628766A (hu) | 1962-12-26 | |||
BE792206A (hu) | 1971-12-02 | 1973-06-01 | Byk Gulden Lomberg Chem Fab | |
US5139998A (en) | 1988-08-31 | 1992-08-18 | Superconductor Technologies, Inc. | Controlled thallous oxide evaporation for thallium superconductor films and reactor design |
SE8803429D0 (sv) * | 1988-09-28 | 1988-09-28 | Pharmacia Ab | Novel pyridyl- and pyrimidyl derivatives |
US5008267A (en) | 1988-10-29 | 1991-04-16 | Mitsui Toatsu Chemicals, Incorporated | Pyrimidinedione compounds, method of producing the same and antiarrythmic agents containing the same |
JP2815218B2 (ja) | 1990-04-13 | 1998-10-27 | 三井化学株式会社 | ピリミジンジオン誘導体、およびそれを含有する抗不整脈剤 |
FR2663638B2 (fr) | 1990-04-06 | 1995-02-10 | Institut Nal Sante Recherc Medic | Polypeptides ayant une activite de recepteur dopaminergique, acides nucleiques codant pour ces polypeptides et utilisation de ces polypeptides pour le criblage de substances actives sur ces polypeptides. |
JP2518965B2 (ja) | 1990-09-21 | 1996-07-31 | 三井東圧化学株式会社 | 新規ピリジン誘導体及びそれを有効成分として含有する制癌剤効果増強剤 |
FR2668771B1 (fr) | 1990-11-06 | 1995-03-17 | Inst Nat Sante Rech Med | Acides nucleiques codant pour des polypeptides ayant une activite de recepteur dopaminergique humain et utilisation de ces polypeptides pour le criblage de substances actives sur ces polypeptides. |
DE4425143A1 (de) | 1994-07-15 | 1996-01-18 | Basf Ag | Substituierte Pyrimidinverbindungen und deren Verwendung |
DE4425146A1 (de) | 1994-07-15 | 1996-01-18 | Basf Ag | Verwendung heterocyclischer Verbindungen |
DE4425145A1 (de) | 1994-07-15 | 1996-01-18 | Basf Ag | Verwendung von Thiazol- und Thiadiazolverbindungen |
DE4425144A1 (de) | 1994-07-15 | 1996-01-18 | Basf Ag | Triazolverbindungen und deren Verwendung |
US5635503A (en) * | 1995-06-07 | 1997-06-03 | Bristol-Myers Squibb Company | Dihydropyridine npy antagonists: piperazine derivatives |
FR2742149B1 (fr) | 1995-12-11 | 1998-02-13 | Inst Nat Sante Rech Med | Nouveaux derives de 2-naphtamides et leurs applications therapeutiques |
-
1996
- 1996-01-12 DE DE19600934A patent/DE19600934A1/de not_active Withdrawn
-
1997
- 1997-01-10 CZ CZ0215998A patent/CZ297981B6/cs not_active IP Right Cessation
- 1997-01-10 DE DE59711847T patent/DE59711847D1/de not_active Expired - Lifetime
- 1997-01-10 SK SK941-98A patent/SK284987B6/sk not_active IP Right Cessation
- 1997-01-10 IL IL12507697A patent/IL125076A/en not_active IP Right Cessation
- 1997-01-10 TR TR1998/01302T patent/TR199801302T2/xx unknown
- 1997-01-10 EP EP97901000A patent/EP0877744B1/de not_active Expired - Lifetime
- 1997-01-10 AT AT97901000T patent/ATE273301T1/de not_active IP Right Cessation
- 1997-01-10 CO CO97000912A patent/CO4790173A1/es unknown
- 1997-01-10 US US09/101,265 patent/US6214822B1/en not_active Expired - Lifetime
- 1997-01-10 ES ES97901000T patent/ES2225947T3/es not_active Expired - Lifetime
- 1997-01-10 JP JP52486997A patent/JP4349657B2/ja not_active Expired - Lifetime
- 1997-01-10 CA CA002241787A patent/CA2241787C/en not_active Expired - Lifetime
- 1997-01-10 WO PCT/EP1997/000106 patent/WO1997025324A1/de active IP Right Grant
- 1997-01-10 HU HU9901590A patent/HU228457B1/hu unknown
- 1997-01-10 AU AU14407/97A patent/AU717726B2/en not_active Expired
- 1997-01-10 CN CN97192755A patent/CN1075070C/zh not_active Expired - Lifetime
- 1997-01-10 ZA ZA97209A patent/ZA97209B/xx unknown
- 1997-01-10 PL PL97327692A patent/PL327692A1/xx unknown
- 1997-01-10 KR KR10-1998-0705263A patent/KR100441073B1/ko not_active IP Right Cessation
- 1997-01-10 NZ NZ326332A patent/NZ326332A/en not_active IP Right Cessation
- 1997-01-10 HR HRP19600934.0A patent/HRP970021A2/hr not_active Application Discontinuation
- 1997-01-13 TW TW086100296A patent/TW475929B/zh not_active IP Right Cessation
- 1997-01-13 AR ARP970100120A patent/AR005868A1/es not_active Application Discontinuation
-
1998
- 1998-07-07 MX MX9805499A patent/MX9805499A/es unknown
- 1998-07-09 BG BG102616A patent/BG64098B1/bg unknown
- 1998-07-10 NO NO19983187A patent/NO316753B1/no not_active IP Right Cessation
-
2000
- 2000-10-27 US US09/696,941 patent/US6352981B1/en not_active Expired - Lifetime
-
2001
- 2001-04-20 CN CNB011170697A patent/CN1146551C/zh not_active Expired - Lifetime
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP9901590A2 (hu) | Szubsztituált aza- és diaza-cikloheptán- és -ciklooktán-származékok, alkalmazásuk, a vegyületeket tartalmazó gyógyászati készítmények | |
PT1140916E (pt) | Acetais heteroarilo ciclicos | |
AR013184A1 (es) | Aminas heterociclicas espiroazobiciclicas, composicion farmaceutica, uso de dichas aminas para preparar medicamentos y metodo de tratamiento o profilaxis | |
HUP0401819A2 (hu) | Proteinkináz inhibitorokként alkalmazható pirazolvegyületek és ezeket tartalmazó gyógyszerkészítmények | |
FI931370A0 (fi) | Kvaeve innehaollande analoger av icke-aromatiska heterocykliska foereningar med en fusionerad ring | |
NZ502181A (en) | Triazole compounds and the use thereof as dopamine-D 3-ligands | |
HUP9601285A2 (hu) | Szubsztituált N-(indol-2-karbonil)-béta-alanin-amidok és származékaik, valamint e vegyületeket tartalmazó gyógyászati készítmények | |
ATE228507T1 (de) | Substituierte 6-phenylphenanthridine | |
DE69224196D1 (de) | 3-aminopiperidine derivate und verwandete stickstoff enthaltende heterocyclische verbindungen | |
TR199801594A2 (xx) | CCR-3 resept�r antagonistleri. | |
HUP0203122A2 (hu) | Fab I inhibitorok, eljárás az előállításukra, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk | |
HUP0301745A2 (hu) | Ciklopentánindolok, ezeket tartalmazó gyógyszerkészítmények és a vegyületek alkalmazása | |
GEP20033001B (en) | Alkynyl-Substituted Quinolin-2-One Derivatives Useful As Anticancer Agents | |
HUP9802865A2 (hu) | N-(szubsztituált fenil-)-pirazol-származékok, előállításuk és alkalmazásuk, a vegyületeket hatóanyagként tartalmazó parazitaellenes készítmények | |
NZ233735A (en) | Heterocyclic substituted aminophenol derivatives | |
EA200300044A1 (ru) | Новые замещенные фталиды, способ их получения и содержащие их фармацевтические композиции | |
TR200200125T2 (tr) | Yeni aminotiyazol türevleri, bunların hazırlanması ve bunları içeren farmasötik kompozisyonlar. | |
HUP0000729A2 (hu) | Új amidszármazékok és ezeket tartalmazó gyógyszerkészítmények | |
MD502G2 (ro) | Derivaţi noi ai adenozinei, procedee de preparare a lor, compoziţii farmaceutice ce le conţin | |
HUP9701921A2 (hu) | Heterociklusos amino-metil-vegyületek, eljárás ezek előállítására és ezeket tartalmazó gyógyászati készítmények | |
GB1424450A (en) | Isoindoline intermediates | |
HUP0303361A2 (hu) | Helyettesített 1-amino-bután-3-ol-származékok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
ES420253A1 (es) | Un procedimiento para preparar nuevos derivados de 2-ami- noindano. | |
BG106937A (en) | Novel indole derivatives | |
HUP9904594A2 (hu) | Piperazinoszármazékok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
GB9A | Succession in title |
Owner name: ABBVIE DEUTSCHLAND GMBH & CO KG, DE Free format text: FORMER OWNER(S): ABBOTT GMBH & CO. KG, DE; BASF AG.,, DE |
|
FH91 | Appointment of a representative |
Free format text: FORMER REPRESENTATIVE(S): RATHONYI ZOLTAN, S.B.G. & K. SZABADALMI UEGYVIVOEI IRODA, HU Representative=s name: SBGK SZABADALMI ES UEGYVEDI IRODAK, HU |